I don't know if it is outside of the scope of the bill. I don't believe it is, and I have suspicions as to what Mr. Lee and Mr. Edwards are going to say, but maybe they could respond to that because it relates to any company that works with the federal government, so that jurisdictional question is clear.
And I do think it is related to safety because we heard very clear testimony that this whole chain of events has to do with prescribing practices. When physicians and others get all this free stuff and they get information that's possibly not correct or misleading and they go to these so-called educationals, we heard about it all. When they see ads in the medical journal that are just ads, promotion, and on that basis they're making very important decisions that affect the health of their patients, I believe it is related to the issue of drug safety and it's related to how people are practising.
I'd like to ask Mr. Lee or Mr. Edwards their opinion on whether or not it's within the scope of the act.